← Eichor
Study identifier: NCT05241405 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer

Condition: Breast Cancer · Fatigue  ·  Sponsor: Centre Francois Baclesse

PhaseNA
Planned participants354
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a multicenter randomized trial in breast cancer patients reporting cancer-related fatigue to evaluate the efficacy and safety of Qiseng® based on extract of American ginseng combined with vitamin C from extract of Camu Camu berries

This description comes directly from the study's public registry record.

Talk to the study team

Carine SEGURA, MD  ·  +33231455050  ·  c.segura@baclesse.unicancer.fr

Alexandra LECONTE  ·  a.leconte@baclesse.unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (10)

ARCOCEA_Clinique EuropeAmiens, FranceNot Yet Recruiting
Ch BayeuxBayeux, FranceNot Yet Recruiting
Centre Pierre CurieBeuvry, FranceNot Yet Recruiting
Centre François BaclesseCaen, FranceRecruiting
Polyclinique du ParcCaen, FranceNot Yet Recruiting
Ch CalaisCalais, FranceRecruiting
Ch CherbourgCherbourg, FranceNot Yet Recruiting
Clinique de FlandreCoudekerque-Branche, FranceRecruiting
Centre Henri BecquerelRouen, FranceRecruiting
Clinique des DentellièresValenciennes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05241405